About
Nitrase Therapeutics develops novel therapeutics based on nitrases, a new class of enzymes involved in protein nitration, targeting a variety of diseases including Parkinson’s disease through their proprietary NITROME platform.
Explore Nitrase's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.